QIBEBT-IR
An autonomous tumor-targeted nanoprodrug for reactive oxygen species-activatable dual-cytochrome c/doxorubicin antitumor therapy
Pei, Yuxia1; Li, Menghuan2; Hou, Yanhua3; Hu, Yan1; Chu, Guangyu4; Dai, Liangliang1; Li, Ke1; Xing, Yuxin1; Tao, Bailong1; Yu, Yonglin1; Xue, Chencheng2; He, Ye1; Luo, Zhong2; Cai, Kaiyong1
2018-06-28
Source PublicationNANOSCALE
ISSN2040-3364
Volume10Issue:24Pages:11418-11429
AbstractThe precise tumor cell-specific delivery of therapeutic proteins and the elimination of side effects associated with routine chemotherapeutic agents are two current critical considerations for tumor therapy. In this study, we report a reactive oxygen species (ROS)-activated yolk-shell nanoplatform for the tumor-specific co-delivery of cytochrome c (Cyt c) prodrug and doxorubicin, in which the bioactivity of Cyt c could be restored by the intracellular ROS-trigger and readily initiate the sequential doxorubicin release. The DOX-loaded lactobionic acid-modified yolk-shell mesoporous silica nanoparticles were first encapsulated with 4-nitrophenyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl carbonate (NBC)-modified Cyt c via boronic ester linkages, and functionalized again with lactobionic acid to further shield Cyt c and confer the selective tumor targeting against liver cancer cells. The key feature in this design is that by taking advantage of the boronic ester linkage, the cytotoxicity of Cyt c capped on the nanoparticle could be temporarily deactivated during blood transportation and rapidly restored upon exposure to the ROS-rich microenvironment within liver cancer cells, thereby simultaneously achieving the protein therapy and stimuli-responsive doxorubicin release. This study presents a novel strategy for the development of tumor-sensitive co-delivery nanoplatforms.
DOI10.1039/c8nr02358a
WOS KeywordMESOPOROUS SILICA NANOPARTICLES ; INTRACELLULAR PROTEIN DELIVERY ; CANCER-THERAPY ; HYDROGEN-PEROXIDE ; FLUORESCENT-PROBE ; DRUG-DELIVERY ; RELEASE ; PRODRUG ; NANOMEDICINE ; NANOCARRIERS
Language英语
Funding ProjectNational Natural Science Foundation of China[51602034] ; National Natural Science Foundation of China[51603024] ; National Key R&D Program of China[2016YFC1100300] ; National Key R&D Program of China[2017YFB0702600] ; China Postdoctoral Science Foundation[2017M612919] ; Innovation Project of the Common Key Technology of Chongqing Science and Technology Industry[cstc2015zdcy-ztzx120003] ; People's Livelihood Special Innovation Projects of Chongqing CSTC[cstc2017shmsA1089] ; Fundamental Research Funds for the Central Universities[10611CDJXZ238826]
WOS Research AreaChemistry ; Science & Technology - Other Topics ; Materials Science ; Physics
Funding OrganizationNational Natural Science Foundation of China ; National Key R&D Program of China ; China Postdoctoral Science Foundation ; Innovation Project of the Common Key Technology of Chongqing Science and Technology Industry ; People's Livelihood Special Innovation Projects of Chongqing CSTC ; Fundamental Research Funds for the Central Universities
WOS SubjectChemistry, Multidisciplinary ; Nanoscience & Nanotechnology ; Materials Science, Multidisciplinary ; Physics, Applied
WOS IDWOS:000436133400022
PublisherROYAL SOC CHEMISTRY
Citation statistics
Document Type期刊论文
Identifierhttp://ir.qibebt.ac.cn/handle/337004/12338
Collection中国科学院青岛生物能源与过程研究所
Corresponding AuthorHu, Yan; Luo, Zhong; Cai, Kaiyong
Affiliation1.Chongqing Univ, Coll Bioengn, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 400044, Peoples R China
2.Chongqing Univ, Sch Life Sci, Chongqing 400044, Peoples R China
3.Chongqing Med & Pharmaceut Coll, Chongqing Engn Res Ctr Pharmaceut Sci, Chongqing 401331, Peoples R China
4.Chinese Acad Sci, Inst Acoust, Qingdao Branch, Qingdao, Peoples R China
Recommended Citation
GB/T 7714
Pei, Yuxia,Li, Menghuan,Hou, Yanhua,et al. An autonomous tumor-targeted nanoprodrug for reactive oxygen species-activatable dual-cytochrome c/doxorubicin antitumor therapy[J]. NANOSCALE,2018,10(24):11418-11429.
APA Pei, Yuxia.,Li, Menghuan.,Hou, Yanhua.,Hu, Yan.,Chu, Guangyu.,...&Cai, Kaiyong.(2018).An autonomous tumor-targeted nanoprodrug for reactive oxygen species-activatable dual-cytochrome c/doxorubicin antitumor therapy.NANOSCALE,10(24),11418-11429.
MLA Pei, Yuxia,et al."An autonomous tumor-targeted nanoprodrug for reactive oxygen species-activatable dual-cytochrome c/doxorubicin antitumor therapy".NANOSCALE 10.24(2018):11418-11429.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Pei, Yuxia]'s Articles
[Li, Menghuan]'s Articles
[Hou, Yanhua]'s Articles
Baidu academic
Similar articles in Baidu academic
[Pei, Yuxia]'s Articles
[Li, Menghuan]'s Articles
[Hou, Yanhua]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Pei, Yuxia]'s Articles
[Li, Menghuan]'s Articles
[Hou, Yanhua]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.